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Introduction 
The problem of increasing efficacy of antitumor therapy has 
recently become acute due to the growth in the number of 
oncological diseases [1]. Surgical therapy, chemotherapy and 
immunotherapy are the main methods used in cancer treatment 
[2a] yet the high toxicity, low bioavailability, poor water 
solubility, low therapeutic indices, and non-targeted delivery of 
antitumor drugs to cancer cells remain the main disadvantages of 
antitumor therapy [2b]. In this regard, development of new water-
soluble molecular capsules capable of increasing the solubility 
and reducing the toxicity of antitumor drugs is an urgent task for 
supramolecular chemistry to address [2c]. Supramolecular 
complexes based on such receptors can be applied to a number of 
problems related to bioavailability and targeted action of the 
therapeutic agents [2]. In the last decade [3], several macrocyclic 
structures have been developed and successfully incorporated in 
supramolecular drug delivery systems [4]. However, poor 
aqueous solubility, which significantly narrows the therapeutic 
window, remains a main problem in the application of 
macrocyclic hosts [3]. Amphiphilic macrocycles capable of 
association and aggregation are considered to be the main 
solution to the above problem [5]. Therefore, we propose to use 
water-soluble decasubstituted pillar[5]arene derivatives 
incorporating fragments of glycine. It is well known [6] that 
structural proteins such as elastin and collagen contain a high 
proportion of glycine residues and that collagen fibrils are 
components of the intercellular matrix which binds cells in 
tissues [6b]. In this work, we report the first example of the use 
of water-soluble pillar[5]arene derivatives containing peptide 
fragments as self-assembling biomimetic systems [7] for drug 
delivery. 
Previously, we developed a technique [8] to introduce glycine 
fragments into the pillar[5]arene structure. Macrocycles 3 and 4 
were obtained by hydrazinolysis, in yields of 78% and 82%, 
respectively, from decaethers 1 and 2. Hydrazide fragments were 
employed as they may allow the target macrocycles to form 
additional intra- and intermolecular hydrogen bonds [6c]. The 
polarity of the amide groups and the ability to protonate the 
terminal amino groups will increase the solubility of the 
substituted macrocycles in water.  
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Hydrazides of glycine-containing decasubstituted pillar[5]arenes were synthesized and 
characterized. Dynamic light scattering (DLS) and transmission electron microscopy (TEM) 
showed that self-assembly into monodisperse spherical nanoparticles (28 nm) was typical in 
water for pillarene hydrazides containing glycylglycide fragments (1×10
-3
 M). Binding of the 
antitumor drug Floxuridine in water by the substituents of the macrocycle was established by 
NMR spectroscopy. It was shown by DLS and TEM, that heating of the macrocycle-Floxuridine 
system in a 1:1 ratio at 1×10
-4
 M led to its self-organization into monodisperse spherical 
particles 132 nm in diameter. 
2009 Elsevier Ltd. All rights reserved. 
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The reactions were carried out in a 3:1 mixture of methanol / 
DMF at ambient temperature for 72 hours. Then self-association 
of macrocycles 3 and 4 and their aggregation with the antitumor 
drug 5-Fluorouracil (5-FU) and its derivative 5-fluoro-2'-
deoxyuridine (Floxuridine) (FUDR) were studied. These drugs 
are used to treat colorectal cancer, liver and stomach cancer [9], 
but their high toxicity causes a large number of side-effects, e.g. 
mouth ulcers, nausea, vomiting, hair loss, stomach ulcers, 
yellowing of the skin and eyes. 
Self-association studies of macrocycles 3 and 4 were carried 
out in water using DLS. Introduction of ten acetohydrazide 
fragments, in the case of 3, appeared insufficient for dissolution 
of the macrocycle in water but the introduction of ten 
acetamidacetohydrazide fragments (4) led to formation of a 
homogeneous aqueous system. Macrocycle 4 self-associated in 
water in a concentration range of 1×10
-3
 to 1×10
-5 
M with 
monodisperse associates (PDI = 0.11, hydrodynamic diameter of 
27.5 nm) were observed at 1×10
-3
 M. According to the TEM 
data, self-associated aggregates of 4 were tightly packed and 
characterized by a spherical shape with an average particle 
diameter of 28 nm (Fig. 2a and 2c). 
Figure 2. TEM images of pillar[5]arene 4 self-associated aggregates 
((a) and (c)) and of pillar[5]arene 4 / FUDR associates ((b) and (d)) 
in water (1×10-3M). (a) and (b): 500 nm scale, (c) and (d): 200 nm 
scale.  
 
The interaction of pillar[5]arene 4 with 5-FU and FUDR was 
studied by DLS, UV-vis and 
1
H, 
13
C, 2D NMR spectroscopy. No 
shifts of the absorption maxima were observed after the addition 
of the macrocycle 4 to 5-FU or FUDR by UV-vis spectroscopy. 
In the case of FUDR, a hypochromic effect in the region of 295 
nm was found. The phenomena are complicated by light 
scattering, resulting in a rising baseline, making interpretation of 
the UV-vis data more difficult. This might be due to the 
aggregation of FUDR with pillar[5]arene 4. 
The DLS investigations of the aggregates showed that a 
polydisperse system was formed from the 4 / FUDR system in 
ratios of 1:1, 1:5, 1:10, 5:1, and 10:1 over a concentration range 
of 1×10
-3 
to 1×10
-5
 M. However, monodisperse (PDI = 0.11) 
aggregates with a hydrodynamic diameter of 131.8 nm were 
formed for both compounds after 30 min of heating the 4 / 
FUDR system (1:1 ratio, 1×10
-4
 M)) at 50 °C (ESI). Thus, self-
organization of the pillar[5]arene 4 with FUDR into 
monodisperse particles was observed only if the mixture was 
heated. With the concentration increased to 1×10
-3
 M and the 
ratio of the macrocycle 4 / FUDR changed to 1:5, 1:10, 5:1, and 
10:1, the aggregate diameter increased to 268.8 nm and PDI 
sharply to 0.50. A polydisperse colloidal system was formed at a 
concentration of 1×10
-2
 M for the 1:1 mixture of 4 and FUDR. 
Unfortunately, the study of the interaction of macrocycle 4 
with FUDR by 
1
H NMR spectroscopy did not allow the nature of 
the interaction to be determined because of the changing position 
of the chemical shifts assigned to the guest and host. This is 
mainly due to signal overlap and broadening spectral lines from 
the formation of the association of macrocycle 4. Therefore, 2D 
1
H-
1
H NOESY NMR (Fig.3) and 2D DOSY spectroscopy and as 
19
F NMR spectroscopy of the antitumor drugs, alone and in 
mixtures with macrocycle 4 were used to confirm the formation 
of the associate.  
 
Figure 3. The 2D 1H-1H NOESY NMR spectrum of the 4 / FUDR 
complex (1:1, 1×10-3 М) in D2O at 25 °C and the proposed structure 
of the complex.  
 
Cross-peaks between the H
5 
protons (methylene groups of 
acetohydrazide fragments) of pillar[5]arene 4 and H
b
, H
d
 and H
c
 
protons of the deoxyribose fragment of FUDR were observed in 
the 2D 
1
H-
1
H NOESY NMR spectrum of the 1:1 mixture of 4 and 
FUDR (1×10
-3
 M) (Fig. 3). The formation of the 4 / FUDR 
Figure 1. Synthesis of the macrocycles 3 and 4: the sketch 
represents pillar[5]arene 4 self-assembly and self-organization of 
the 4 / FUDR system into monodisperse spherical particles 
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associate was additionally confirmed by 2D DOSY spectroscopy 
(ESI). Diffusion coefficients of 1×10
-3
 M 4, FUDR and 4 / 
FUDR were determined at 298 K (ESI). The DOSY spectrum of 
the 1:1 mixture of 4 and FUDR (1×10
-3
 M) showed the presence 
of only a single species of particles with a diffusion coefficient 
below that of the macrocyclic ligand 4 and the antitumor drug 
FUDR. A significant decrease in the diffusion rate of 4 / FUDR 
is an additional argument in favor of the formation of stable 
associates between 4 and FUDR. 
According to the TEM data, associates of pillar[5]arene 4 with 
FUDR are characterized by a spherical shape and average 
diameter of 130 nm (Fig.2b and 2d.). No cross-peaks in the 2D 
1
H-
1
H NOESY NMR spectrum between the protons of 
macrocycle 4 and proton (δ = 8.02 ppm) of the fluorouracil 
fragment in FUDR was observed. This made it possible to 
propose the formation of the associate due to hydrogen bonds 
between the fragments of deoxyribose in FUDR and the amide 
and hydrazide groups of the pillar[5]arene 4. The absence of 
significant displacements of the FUDR proton signals in the 
1
H 
NMR spectrum indicated that the substrate molecules did not 
enter the hydrophobic cavity of the macrocycle 4 [10a]. Studying 
the 
19
F NMR spectra with proton decoupling of 5-FU, FUDR and 
4 / 5-FU and 4 / FUDR mixtures is a convenient way to confirm 
this hypothesis because 5-FU and FUDR molecules contain a 
single fluorine atom that is detected by 
19
F NMR spectroscopy. If 
5-FU and FUDR molecules are included in the cavity of 
pillar[5]arene 4, the fluorine atom is shielded and its signal shifts 
to a strong field [10 b, c]. Study on the 4 / 5-FU system in a 1:1 
ratio (1×10
-3
 M) showed no displacement of the 
19
F signals vs. 
initial value of the fluorine signal of 5-FU (Δδ ~ 0.02 ppm) (Fig. 
4). However, in case of the 4 / FUDR system (1:1 ratio, 1×10
-3
 
M), the fluorine signal was shifted by Δδ ~ 1.30 ppm (Fig.4) 
against that in free FUDR. Based on this, it can be concluded that 
the downfield shift of the fluorine signal in the system of 4 / 
FUDR indicates no inclusion of the FUDR molecule in the 
cavity of the macrocycle 4. De-shielding of the fluorine atom is 
caused by formation of the hydrogen bonds of the deoxyribose 
moiety and fluorine atom with the amide groups of pillar[5]arene 
4. 
 
Figure 3. 19F NMR spectra with proton decoupling (1×10-3 М) in 
D2O at 25 °C: 1) FUDR; 2) 4 / FUDR in the 1:1 ratio; 3) 5-FU; 4) 4 
/ 5-FU in the 1:1 ratio.  
 
Further confirmation of this hypothesis was found in the 
additional study of the 2D 
1
H-
1
H NOESY NMR spectrum of the 
1:1 mixture of 4 and deoxyribose (1×10
-3
 M) (ESI). Cross-peaks 
between protons H
5
, H
4
 and H
3
 (the methylene groups of 
acetohydrazide and acetamide fragments) of pillar[5]arene 4 and 
the deoxyribose protons in the 2D 1H-1H NOESY NMR 
spectrum of the 1:1 4/deoxyribose mixture (1×10
-3
 M) 
undoubtedly indicate formation of the 4/deoxyribose associate 
by intermolecular hydrogen bonds between amide fragments of 
pillar[5]arene 4 and deoxyribose protons. The orientation of the 
FUDR molecule inside pillar[5]arene 4 was studied by 
computational methods and found to be in agreement with the 
NMR interpretation (ESI). 
A series of experiments to assess the viability of cells under 
treatment with pillar[5]arenes 3 and 4 was carried out. Survival 
was determined after incubation of the cells with the 
pillar[5]arenes for 24, 48 and 72 h. In the samples, cells survival 
was expressed in relative units against the control with no 
pillar[5]arenes. In the study of compound 3 (25 and 50 μg / ml), 
an appropriate amount of deionized water was added to the 
control. Compound 3 appeared to be more toxic than 4 with a 
decreased survival at a concentration of 25-50 μg/ml. 
Pillar[5]arene 4 (250 and 500 μg/ml) was non-toxic throughout 
the 24 h treatment. A small concentration-dependent viability 
suppression was found for incubation times of 48 h and 72 h. In 
general, the toxicity of 4 is weak even at high concentration 
(ESI). 
In conclusion, water-soluble decasubstituted pillar[5]arenes 
containing hydrazide fragments of glycine and glycylglycine 
were synthesized for the first time. DLS showed that 1×10
-3
 M 
pillar[5]arene 4 containing acetamidacetohydrazide fragments 
formed monodisperse associates in aqueous solution with a PDI 
of 0.11 and a hydrodynamic diameter of 27.5 nm. Association of 
macrocycle 4 with the antitumor drug 5-fluoro-2'-deoxyuridine 
(FUDR) was demonstrated by DLS, UV-vis and 
1
H, 
13
C, 2D 
NMR spectroscopy. As a result of 1:1 association, monodisperse 
nanosized particles with a PDI of 0.11 and a hydrodynamic 
diameter of 131.8 nm at 1×10
-4
 M were formed by both 
compounds. The formation of nano-sized particles with a 
diameter of 130 nm was shown by TEM. The formation of the 4 / 
FUDR associates occurred as "head to head" species with the 
fluorine atom directed towards the macrocyclic cavity of the 
pillar[5]arene and the deoxyribose FUDR fragment outwards as 
followed from the 2D 
1
H-
1
H NOESY and 
19
F NMR spectroscopy. 
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